comparemela.com

Latest Breaking News On - Mary de wet - Page 1 : comparemela.com

Autodesk Posts Higher 1Q Revenue After Accounting-Probe Delay

By Mary de Wet Autodesk reported higher revenue in its fiscal first quarter, boosted by design and subscription-plan sales, after an accounting probe delayed the company s filing of its annual.

Autodesk
Mary-de-wet
San-francisco-based
Dow-jones

Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment

By Mary de Wet Relay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast cancer. .

Centers-for-disease
Genentech
Pfizer
Mary-de-wet
Disease-control
Dow-jones

Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment

Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Centers-for-disease
Genentech
Pfizer
Dow-jones-company-inc
Mary-de-wet
Disease-control
Dow-jones

TPC Group Agrees to Pay Over $30 Million in Criminal Fines and Civil Penalties

By Mary de Wet TPC Group has pleaded guilty to violating the Clean Air Act four years ago and agreed to pay more than $30 million in criminal fines and civil penalties. The Texas. -May 21, 2024 at 04:20 pm EDT - MarketScreener

Houston
Texas
United-states
Port-neches
Environmental-protection-agency
Justice-department
Mary-de-wet
Clean-air-act
Hazard-investigation-board
Air-act
Dow-jones

Altria's NJOY Submits Application to FDA for Vaping Device With Access-Restriction Tech

By Mary de Wet Altria s e-cigarette arm NJOY has submitted an application to the U.S. Food and Drug Administration to market a vaping device that has technology designed to prevent underage. -May 20, 2024 at 05:13 pm EDT - MarketScreener

Drug-administration
Mary-de-wet
Dow-jones

vimarsana © 2020. All Rights Reserved.